Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zevra Therapeutics (ZVRA) Tax Provisions: 2013-2024

Historic Tax Provisions for Zevra Therapeutics (ZVRA) over the last 11 years, with Dec 2024 value amounting to $15.4 million.

  • Zevra Therapeutics' Tax Provisions was N/A to -$433,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $18.3 million, marking a year-over-year change of. This contributed to the annual value of $15.4 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Zevra Therapeutics' Tax Provisions is $15.4 million, which was up 46,678.79% from -$33,000 recorded in FY2022.
  • Over the past 5 years, Zevra Therapeutics' Tax Provisions peaked at $15.4 million during FY2024, and registered a low of -$34,000 during FY2020.
  • In the last 2 years, Zevra Therapeutics' Tax Provisions had a median value of $7.7 million in 2022 and averaged $7.7 million.
  • Per our database at Business Quant, Zevra Therapeutics' Tax Provisions soared by 200.00% in 2021 and then tumbled by 197.06% in 2022.
  • Over the past 4 years, Zevra Therapeutics' Tax Provisions (Yearly) stood at -$34,000 in 2020, then surged by 200.00% to $34,000 in 2021, then plummeted by 197.06% to -$33,000 in 2022, then reached $15.4 million in 2024.